Outcomes of the May 2021 PBAC intracycle meeting

18 June 2021 - The outcomes from the May 2021 PBAC meeting are now available. ...

Read more →

Efficient funding of chemotherapy review - submissions on discussion paper

18 June 2021 - The efficient funding of chemotherapy review discussion paper was released on 21 May 2021 to gain ...

Read more →

Let's have permanently quicker drug approvals

16 June 2021 - New drugs and vaccines likely to increase life expectancy, quality of life and save money, so we ...

Read more →

Vaccine confusion as clots force jab switch for two million

17 June 2021 - Health authorities are scrambling to switch more than two million Australians aged under 60 to the ...

Read more →

Shared decision making underpins good health care

17 June 2021 - Shared decision making between service users and health care professionals is an integral part of health care, ...

Read more →

Expanded PBS listing to save Australians around $120,000 a year

17 June 2021 - More than 800 Australians with stage IV advanced or metastatic kidney cancer will now have improved access ...

Read more →

German law makers seek to ease reimbursement for advanced therapies

15 June 2021 - Advanced therapy trade group The Alliance for Regenerative Medicine has highlighted the passage of a new ...

Read more →

Health care funding decisions and real world benefits: reducing bias by matching untreated patients

14 June 2021 - Governments and health insurers often make funding decisions based on health gains from randomised controlled trials.  ...

Read more →

How the patient voice is becoming vital for drug approval

14 June 2021 - Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a ...

Read more →

Uptake of medicines for type 2 diabetes mellitus

15 June 2021 - Empagliflozin (with and without metformin hydrochloride) has been funded since 1 February 2021. It is funded for ...

Read more →

Opdivo plus Yervoy scores NICE backing for certain bowel cancer patients

14 June 2021 - Bristol Myers Squibb’s immunotherapy combination Opdivo plus Yervoy has been recommended by NICE for the treatment ...

Read more →

NICE to reassess Kyowa Kirin’s Poteligeo

14 June 2021 - NICE will reassess Kyowa Kirin’s rare blood cancer treatment Poteligeo after upholding an appeal launched by ...

Read more →

PHARMAC’s decision over diabetes drugs could see up to 140,000 ‘miss out’, doctor says

11 June 2021 - Dr John Baker​, the chair of the Diabetes Foundation Aotearoa, says that has to change and highlights ...

Read more →

Astellas’ Xtandi bags NICE approval in prostate cancer

10 June 2021 - Astellas’ oral treatment Xtandi has received approval from NICE for the treatment of metastatic hormone-sensitive prostate ...

Read more →

NICE recommends several treatment options to help thousands with moderate rheumatoid arthritis

10 June 2021 - Around 25,000 people with moderate rheumatoid arthritis that has not responded to conventional therapies are set to ...

Read more →